F-18 fluoride positron emission tomography of the hip for osteonecrosis

被引:49
|
作者
Dasa, Vinod [3 ]
Adbel-Nabi, Hani [2 ]
Anders, Mark J. [3 ]
Mihalko, William M. [1 ]
机构
[1] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22908 USA
[2] Univ Buffalo, Dept Nucl Med, Buffalo, NY USA
[3] Univ Buffalo, Dept Orthopaed Surg, Buffalo, NY USA
关键词
D O I
10.1007/s11999-008-0219-2
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Osteonecrosis (ON) of the femoral head continues to be a devastating disorder for young patients. We evaluated the F-18 fluoride positron emission tomography (PET) imaging modality for use in detection of the bone involved in ON of the hip. We retrospectively reviewed the records of 60 consecutive patients diagnosed with ON and interviewed all by phone. Eleven patients (17 hips) of those interviewed agreed to participate in the study. We classified the ON using the University of Pennsylvania classification system and compared each patient's plain AP bone scan, single photon emission 3-D computed tomography, and MRI. ON was associated with HIV, alcohol, steroid use, and polycythemia vera in this group. Nine of 17 hips (8 patients) had acetabular increased uptake when using the F-18 fluoride PET scans that were not seen on MRI, single photon emission computed tomography, or bone scans. These data suggest earlier acetabular changes in osteonecrosis may exist that traditional imaging modalities do not reveal. Level of Evidence: Level III, diagnostic study. See the Guidelines for Authors for a complete description of levels of evidence.
引用
收藏
页码:1081 / 1086
页数:6
相关论文
共 50 条
  • [21] STANDARDIZATION OF F-18 FOR USE IN POSITRON-EMISSION TOMOGRAPHY
    COURSEY, BM
    HOPPES, DD
    UNTERWEGER, MP
    MALONDA, AG
    MARGOLIN, RA
    KESSLER, RM
    MANNING, R
    INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1983, 34 (08): : 1181 - 1189
  • [22] F-18 CHEMISTRY AND ITS APPLICATION TO POSITRON EMISSION TOMOGRAPHY
    WOLF, AP
    JOURNAL OF FLUORINE CHEMISTRY, 1983, 23 (05) : 412 - 412
  • [23] Labeling Strategies with F-18 for Positron Emission Tomography Imaging
    Gu, Yonghong
    Huang, Dong
    Liu, Zhiguo
    Huang, Jiaguo
    Zeng, Wenbin
    MEDICINAL CHEMISTRY, 2011, 7 (05) : 334 - 344
  • [24] Use of 18F-fluoride positron emission tomography as a predictor of the hip osteoarthritis progression
    Kobayashi, Naomi
    Inaba, Yutaka
    Yukizawa, Yohei
    Ike, Hiroyuki
    Kubota, So
    Inoue, Tomio
    Saito, Tomoyuki
    MODERN RHEUMATOLOGY, 2015, 25 (06) : 925 - 930
  • [25] Added Value of Using a Cocktail of F-18 Sodium Fluoride and F-18 Fluorodeoxyglucose in Positron Emission Tomography/Computed Tomography for Detecting Bony Metastasis A Case Report
    Chan, Hung-Pin
    Hu, Chin
    Yu, Chang-Ching
    Huang, Tsung-Chi
    Peng, Nan-Jing
    MEDICINE, 2015, 94 (13)
  • [26] Brain: Positron Emission Tomography Tracers Beyond [F-18] Fluorodeoxyglucose
    Singhal, Tarun
    Alavi, Abass
    Kim, Chun K.
    PET CLINICS, 2014, 9 (03) : 267 - +
  • [27] F-18 fluorodeoxyglucose positron emission tomography for uterine and adnexal carcinosarcoma
    Hayasaka, K.
    Takizawa, K.
    Nihashi, T.
    Koyama, M.
    Saitoh, T.
    Miwa, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S463 - S463
  • [28] F-18 Fluorodeoxyglucose positron emission tomography/computed tomography in tuberculosis of the hip: A case report and brief review of literature
    D'Souza, Maria Mathew
    Sharma, Rajnish
    Tripathi, Madhavi
    Mondal, Anupam
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2011, 26 (01): : 31 - 33
  • [29] F-18 FDG positron emission tomography demonstration of pulmonary carcinoid
    Jain, M
    Yung, E
    Trow, T
    Katz, DS
    CLINICAL NUCLEAR MEDICINE, 2004, 29 (06) : 370 - 371
  • [30] A POSITRON EMISSION TOMOGRAPHY [F-18] DEOXYGLUCOSE STUDY OF DEVELOPMENTAL STUTTERING
    WU, JC
    MAGUIRE, G
    RILEY, G
    FALLON, J
    LACASSE, L
    CHIN, S
    KLEIN, E
    TANG, C
    CADWELL, S
    LOTTENBERG, S
    NEUROREPORT, 1995, 6 (03) : 501 - 505